immune system

For more recent posts, please follow my LinkedIn profile.

Published on
November 28, 2022
New initiative to INDICATE cancer risk
interdisciplinary project MathOnco Heidelberg Lynch syndrome immune system
I am proud to be part of a new international collaborative initiative, called INDICATE, to unravel the role of the Human Leukocyte Antigen type as a cancer risk modifier in individuals with Lynch syndrome.